SLE (Systemic Lupus) Clinical Trials
4 recruiting trials for SLE (Systemic Lupus). Eligibility criteria explained in plain English.
4
Total Trials
4
Recruiting Now
0
Phase 3 Trials
4
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus...
Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE).
Sponsor: Cullinan Therapeutics Inc.Enrolling: 2415 locations
RECRUITINGNCT04604990
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no...
Sponsor: King Saud UniversityEnrolling: 10001 location
RECRUITINGPhase 1NCT06056921
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
This is a single arm study to evaluate the efficacy and safety of CD19 targeted CAR-T cells therapy for patients with Refractory Autoimmune Disease
Sponsor: Chongqing Precision Biotech Co., LtdEnrolling: 241 location
RECRUITINGPhase 1NCT06925542
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune...
Sponsor: CRISPR TherapeuticsEnrolling: 808 locations